Charles Cha MD

Hepatobiliary Surgery, Surgical Oncology (Other than Breast), Minimally Invasive Surgery

Chief of Surgical Oncology, Saint Vincent’s Medical Center Director of Surgical Oncology for Fairfield County Medical Director of the Digestive Health Center, Fairfield County at Hartford HealthCare Medical Group

Join to view full profile

2800 Main StFl 3Bridgeport, CT 06606
Phone+1 203-576-6141
Fax+1 203-581-6587

Dr. Cha is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cha's full profile Already have an account?

Summary

Dr. Charles Cha is a general surgeon based in Bridgeport, CT, with subspecialties in hepatobiliary surgery, surgical oncology, and minimally invasive surgery. A graduate of Northwestern University The Feinberg School of Medicine in 1995, Dr. Cha completed a residency in surgery at University of Wisconsin Hospitals and Clinics and a fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center. Currently, Dr. Cha serves as Chief of Surgical Oncology at St. Vincent's Medical Center and formerly an Associate Professor at Yale School of Medicine. Dr. Cha’s expertise includes biliary tract and pancreatic diseases, minimally invasive surgery, and non-breast surgical oncology. Dr. Cha has published several peer-reviewed articles and has been recognized as one of the Best Doctors in New York and Connecticut.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2001 - 2003
University of Wisconsin Hospitals and ClinicsResidency, Surgery, 1995 - 2001
Northwestern University The Feinberg School of MedicineClass of 1995

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CT State Medical License 2003 - 2027
FL State Medical License 2012 - 2014
NY State Medical License 2000 - 2004
WI State Medical License 1996 - 2001
American Board of Surgery Surgery

Awards, Honors, & Recognition

Best Doctors in Connecticut Connecticut Magazine, 2020
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017

Publications & Presentations

PubMed

Prognostic implications of margin status in association with systemic treatment in a cohort study of patients with resection of colorectal liver metastases.
Omeed Moaven, Bigyan B Mainali, Cristian D Valenzuela, Gregory Russell, Tanto Cheung
Journal of Surgical Oncology. 2024-12-01
3 citations
Resection versus resection with ablation: Analysis from the colorectal liver operative metastasis international collaborative.
Bigyan B Mainali, Cristian D Valenzuela, Omeed Moaven, John A Stauffer, Nico R Del Piccolo
Journal of Surgical Oncology. 2024-09-01
28 citations
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.
Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha
JAMA Oncology. 2024-08-01

Lectures

Yale Cancer Center Evening Oncology Series: Gastrointestinal Cancers
Yale CME, New Haven, Connecticut - 9/20/2012
Hepatocellular Carcinoma in the Community
Yale CME, New Haven, Connecticut - 4/13/2012